News Corp revenue rises on real estate and publishing growth
News Corp reported 3% revenue growth for the quarter that ended in March, driven by positive foreign-exchange fluctuations plus solid growth at the company’s digital real estate, book publishing and Dow Jones units.
Beyond Meat burned by COVID-19 restaurant trends
Beyond Meat shares sank on Thursday as the company explained pandemic pressures caused it to fall short of earnings expectations.
Peloton’s bike wait time back to pre-COVID-19 levels
Peloton reported revenue growth of $1.26 billion in the quarter, up 141%, driven by strong demand for its Connected Fitness Products, an acceleration of deliveries and low churn levels.
Dow gains 318 points, Nasdaq rebounds with jobs data Friday
U.S. stocks see a rally across the board ahead of Friday's jobs report.
Time for market rest after ‘off the charts’ economy, earnings: Bob Doll
Former Nuveen chief equity strategist and senior portfolio manager Bob Doll discusses how worried investors should be about the markets in the coming months.
Pay Pal soars on digital payments boom
PayPal Holdings Inc reported its strongest first quarter on record and beat profit estimates on Wednesday, with a coronavirus-driven shift to online shopping and digital transactions boosting payment volumes.
Uber gross bookings hit all-time high of $19.5B as economy reopens
Uber narrowed its net losses from $2.93 billion to $108 million, primarily due to a $1.6 billion benefit from the sale of its ATG self-driving unit.
Fox Corp. acquires Clay Travis’s Outkick in sports betting play
Fox's Outkick acquisition will up its game in the red hot world of sports betting.
Dow hits record, Nasdaq falls for 4th session
Stock investors eye GM, jobs data and Trump's Facebook ban which was upheld.
Lyft rides increased demand for service
Lyft Inc. said demand for rides improved in the first quarter compared with much of last year when the pandemic sunk ridership.
Is inflation the real threat to the markets?
Strategic Wealth Partners president Mark Tepper, Belpointe chief strategist David Nelson and Peapack Private Wealth Management managing principal David Dietze discuss the state of the economy.
This is an ‘opportunity to buy the dip’: Market expert
Panel on today’s markets
Dow bounces higher as Nasdaq, S&P drop on Yellen's rate hike talk
Stock investors are rotating into cyclical names and out of technology.
Investors should buy tech stocks in market pullbacks: Investment strategist
BMO Capital Markets chief investment strategist Brian Belski on his outlook for the market, sharing that he is still bullish for the long-term.
CVS raises outlook on COVID-19, Medicare products
CVS Health beat Wall Street expectations and after releasing projections earlier this year that disappointed analysts, a new outlook Tuesday exceeds those levels.
Pfizer’s COVID-19 vaccine lifts quarterly results
Pfizer Inc. significantly increased revenue projections from its Covid-19 vaccine for the year, as sales from the shot over the first three months of 2021 lifted the company to a stronger quarterly profit.
What to expect from markets in May
Kaltbaum Capital Management President Gary Kaltbaum, Kadina Group president Gary B. Smith and Payne Capital Management President Ryan Payne discuss the markets, Biden’s spending plans and economic recovery.
Stocks near records as COVID-19 restrictions drop across states
Stocks rise in anticipation of more positive earnings reports set for this week with over 130 companies on the docket.
Record share of companies are beating earnings estimates
With the earnings season more than halfway over, most companies in the S&P 500 have surpassed analysts’ profit expectations. As of Friday, results from 87% of those that have reported were better than expected, according to Refinitiv. That is above the historical average of 65% and on pace for the highest share since Refinitiv began tracking the metric in 1994.
Pfizer, GM earnings and jobs report top week ahead
A busy earnings week includes GM, Pfizer results as well as the upcoming trial for disgraced former Theranos CEO Elizabeth Holmes.